VERTEX PHARMACEUTICALS INC / MA Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for August 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 77.31 | 1,289 | 99,653 | 2,578 | |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 152.88 | 1,289 | 197,062 | 16,634 | 17.9 K to 16.6 K (-7.19 %) |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 77.31 | 1,289 | 99,653 | 17,923 | 16.6 K to 17.9 K (+7.75 %) |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 77.31 | 4,250 | 328,568 | 8,500 | |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 152.88 | 4,250 | 649,740 | 121,117 | 125.4 K to 121.1 K (-3.39 %) |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 77.31 | 4,250 | 328,568 | 125,367 | 121.1 K to 125.4 K (+3.51 %) |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 77.31 | 4,250 | 328,568 | 8,500 | |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 156.02 | 1,250 | 195,025 | 115,888 | 117.1 K to 115.9 K (-1.07 %) |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 155.29 | 2,600 | 403,754 | 117,138 | 119.7 K to 117.1 K (-2.17 %) |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 154.09 | 400 | 61,636 | 119,738 | 120.1 K to 119.7 K (-0.33 %) |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 77.31 | 4,250 | 328,568 | 120,138 | 115.9 K to 120.1 K (+3.67 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 109.14 | 4,250 | 463,845 | 25,500 | |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 155.72 | 4,250 | 661,810 | 121,117 | 125.4 K to 121.1 K (-3.39 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 109.14 | 4,250 | 463,845 | 125,367 | 121.1 K to 125.4 K (+3.51 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 91.05 | 2,155 | 196,213 | 21,552 | |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 156.09 | 455 | 71,021 | 115,888 | 116.3 K to 115.9 K (-0.39 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 154.55 | 700 | 108,185 | 116,343 | 117 K to 116.3 K (-0.60 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 153.57 | 500 | 76,785 | 117,043 | 117.5 K to 117 K (-0.43 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 152.49 | 500 | 76,245 | 117,543 | 118 K to 117.5 K (-0.42 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 91.05 | 2,155 | 196,213 | 118,043 | 115.9 K to 118 K (+1.86 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 86.52 | 2,330 | 201,592 | 32,619 | |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 155.72 | 2,330 | 362,828 | 28,809 | 31.1 K to 28.8 K (-7.48 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 86.52 | 2,330 | 201,592 | 31,139 | 28.8 K to 31.1 K (+8.09 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 109.14 | 3,594 | 392,249 | 21,563 | |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 1,796 | 163,526 | 17,960 | |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 155.15 | 500 | 77,575 | 114,424 | 114.9 K to 114.4 K (-0.44 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 154.21 | 2,494 | 384,600 | 114,924 | 117.4 K to 114.9 K (-2.12 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 153.29 | 600 | 91,974 | 117,418 | 118 K to 117.4 K (-0.51 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 109.14 | 3,594 | 392,249 | 118,018 | 114.4 K to 118 K (+3.14 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 156.24 | 296 | 46,247 | 114,424 | 114.7 K to 114.4 K (-0.26 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 154.89 | 400 | 61,956 | 114,720 | 115.1 K to 114.7 K (-0.35 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 153.93 | 600 | 92,358 | 115,120 | 115.7 K to 115.1 K (-0.52 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 152.50 | 500 | 76,250 | 115,720 | 116.2 K to 115.7 K (-0.43 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 1,796 | 163,526 | 116,220 | 114.4 K to 116.2 K (+1.57 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 91.05 | 1,289 | 117,363 | 12,891 | |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 151.80 | 1,289 | 195,670 | 16,634 | 17.9 K to 16.6 K (-7.19 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 91.05 | 1,289 | 117,363 | 17,923 | 16.6 K to 17.9 K (+7.75 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 83.36 | 860 | 71,690 | 0 | |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 152.99 | 860 | 131,571 | 16,634 | 17.5 K to 16.6 K (-4.92 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 83.36 | 860 | 71,690 | 17,494 | 16.6 K to 17.5 K (+5.17 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 83.36 | 2,125 | 177,140 | 0 | |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 152.99 | 2,125 | 325,104 | 121,117 | 123.2 K to 121.1 K (-1.72 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 83.36 | 2,125 | 177,140 | 123,242 | 121.1 K to 123.2 K (+1.75 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 45.11 | 11,063 | 499,052 | 55,313 | |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 154.05 | 700 | 107,835 | 257,392 | 258.1 K to 257.4 K (-0.27 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 153.24 | 5,000 | 766,200 | 258,092 | 263.1 K to 258.1 K (-1.90 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 152.25 | 5,363 | 816,517 | 263,092 | 268.5 K to 263.1 K (-2.00 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 45.11 | 11,063 | 499,052 | 268,455 | 257.4 K to 268.5 K (+4.30 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 83.36 | 2,125 | 177,140 | 0 | |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 154.13 | 100 | 15,413 | 115,888 | 116 K to 115.9 K (-0.09 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 153.30 | 1,100 | 168,630 | 115,988 | 117.1 K to 116 K (-0.94 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 152.24 | 925 | 140,822 | 117,088 | 118 K to 117.1 K (-0.78 %) |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 83.36 | 2,125 | 177,140 | 118,013 | 115.9 K to 118 K (+1.83 %) |